These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 1559293

  • 1. Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome.
    Kiddy DS, Hamilton-Fairley D, Bush A, Short F, Anyaoku V, Reed MJ, Franks S.
    Clin Endocrinol (Oxf); 1992 Jan; 36(1):105-11. PubMed ID: 1559293
    [Abstract] [Full Text] [Related]

  • 2. The role of nutrition and insulin in the regulation of sex hormone binding globulin.
    Franks S, Kiddy DS, Hamilton-Fairley D, Bush A, Sharp PS, Reed MJ.
    J Steroid Biochem Mol Biol; 1991 Nov; 39(5B):835-8. PubMed ID: 1954173
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of ovarian functionality after a dietary treatment in obese women with polycystic ovary syndrome.
    Tolino A, Gambardella V, Caccavale C, D'Ettore A, Giannotti F, D'Antò V, De Falco CL.
    Eur J Obstet Gynecol Reprod Biol; 2005 Mar 01; 119(1):87-93. PubMed ID: 15734091
    [Abstract] [Full Text] [Related]

  • 4. Response of sex hormone binding globulin and insulin-like growth factor binding protein-1 to an oral glucose tolerance test in obese women with polycystic ovary syndrome before and after calorie restriction.
    Hamilton-Fairley D, Kiddy D, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1993 Sep 01; 39(3):363-7. PubMed ID: 7693380
    [Abstract] [Full Text] [Related]

  • 5. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome.
    Nestler JE, Powers LP, Matt DW, Steingold KA, Plymate SR, Rittmaster RS, Clore JN, Blackard WG.
    J Clin Endocrinol Metab; 1991 Jan 01; 72(1):83-9. PubMed ID: 1898744
    [Abstract] [Full Text] [Related]

  • 6. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
    Pasquali R, Gambineri A, Biscotti D, Vicennati V, Gagliardi L, Colitta D, Fiorini S, Cognigni GE, Filicori M, Morselli-Labate AM.
    J Clin Endocrinol Metab; 2000 Aug 01; 85(8):2767-74. PubMed ID: 10946879
    [Abstract] [Full Text] [Related]

  • 7. Effect of long-term orlistat treatment on serum levels of advanced glycation end-products in women with polycystic ovary syndrome.
    Diamanti-Kandarakis E, Katsikis I, Piperi C, Alexandraki K, Panidis D.
    Clin Endocrinol (Oxf); 2007 Jan 01; 66(1):103-9. PubMed ID: 17201808
    [Abstract] [Full Text] [Related]

  • 8. Lack of linear relationship between hyperinsulinaemia and hyperandrogenism.
    Toscano V, Bianchi P, Balducci R, Guglielmi R, Mangiantini A, Lubrano C, Sciarra F.
    Clin Endocrinol (Oxf); 1992 Feb 01; 36(2):197-202. PubMed ID: 1533185
    [Abstract] [Full Text] [Related]

  • 9. Effects of Dietary Approach to Stop Hypertension diet on androgens, antioxidant status and body composition in overweight and obese women with polycystic ovary syndrome: a randomised controlled trial.
    Azadi-Yazdi M, Karimi-Zarchi M, Salehi-Abargouei A, Fallahzadeh H, Nadjarzadeh A.
    J Hum Nutr Diet; 2017 Jun 01; 30(3):275-283. PubMed ID: 28466507
    [Abstract] [Full Text] [Related]

  • 10. The effect of weight loss on inflammation in obese women with polycystic ovary syndrome.
    Olszanecka-Glinianowicz M, Zahorska-Markiewicz B, Kocełak P, Janowska J, Semik-Grabarczyk E.
    Endokrynol Pol; 2008 Jun 01; 59(1):13-7. PubMed ID: 18335395
    [Abstract] [Full Text] [Related]

  • 11. Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
    Huber-Buchholz MM, Carey DG, Norman RJ.
    J Clin Endocrinol Metab; 1999 Apr 01; 84(4):1470-4. PubMed ID: 10199797
    [Abstract] [Full Text] [Related]

  • 12. The independent effects of polycystic ovary syndrome and obesity on serum concentrations of gonadotrophins and sex steroids in premenopausal women.
    Holte J, Bergh T, Gennarelli G, Wide L.
    Clin Endocrinol (Oxf); 1994 Oct 01; 41(4):473-81. PubMed ID: 7955458
    [Abstract] [Full Text] [Related]

  • 13. Obesity, weight loss, and the polycystic ovary syndrome: effect of treatment with diet and orlistat for 24 weeks on insulin resistance and androgen levels.
    Panidis D, Farmakiotis D, Rousso D, Kourtis A, Katsikis I, Krassas G.
    Fertil Steril; 2008 Apr 01; 89(4):899-906. PubMed ID: 17980364
    [Abstract] [Full Text] [Related]

  • 14. The relation between clinical manifestations of polycystic ovary syndrome and beta-cell function.
    Weber RF, Pache TD, Jacobs ML, Docter R, Loriaux DL, Fauser BC, Birkenhäger JC.
    Clin Endocrinol (Oxf); 1993 Mar 01; 38(3):295-300. PubMed ID: 8458101
    [Abstract] [Full Text] [Related]

  • 15. Effect of Dietary Weight Loss on Menstrual Regularity in Obese Young Adult Women with Polycystic Ovary Syndrome.
    Marzouk TM, Sayed Ahmed WA.
    J Pediatr Adolesc Gynecol; 2015 Dec 01; 28(6):457-61. PubMed ID: 26298524
    [Abstract] [Full Text] [Related]

  • 16. Dyslipidaemia is associated with insulin resistance in women with polycystic ovaries.
    Robinson S, Henderson AD, Gelding SV, Kiddy D, Niththyananthan R, Bush A, Richmond W, Johnston DG, Franks S.
    Clin Endocrinol (Oxf); 1996 Mar 01; 44(3):277-84. PubMed ID: 8729522
    [Abstract] [Full Text] [Related]

  • 17. The natural history of the metabolic syndrome in young women with the polycystic ovary syndrome and the effect of long-term oestrogen-progestagen treatment.
    Pasquali R, Gambineri A, Anconetani B, Vicennati V, Colitta D, Caramelli E, Casimirri F, Morselli-Labate AM.
    Clin Endocrinol (Oxf); 1999 Apr 01; 50(4):517-27. PubMed ID: 10468913
    [Abstract] [Full Text] [Related]

  • 18. The effect of vitamin D supplementation in combination with low-calorie diet on anthropometric indices and androgen hormones in women with polycystic ovary syndrome: a double-blind, randomized, placebo-controlled trial.
    Jafari-Sfidvajani S, Ahangari R, Hozoori M, Mozaffari-Khosravi H, Fallahzadeh H, Nadjarzadeh A.
    J Endocrinol Invest; 2018 May 01; 41(5):597-607. PubMed ID: 29110281
    [Abstract] [Full Text] [Related]

  • 19. How common are polycystic ovaries and the polycystic ovarian syndrome in women with Cushing's syndrome?
    Kaltsas GA, Korbonits M, Isidori AM, Webb JA, Trainer PJ, Monson JP, Besser GM, Grossman AB.
    Clin Endocrinol (Oxf); 2000 Oct 01; 53(4):493-500. PubMed ID: 11012575
    [Abstract] [Full Text] [Related]

  • 20. Diurnal variation of sex hormone binding globulin and insulin-like growth factor binding protein-1 in women with polycystic ovary syndrome.
    Hamilton-Fairley D, White D, Griffiths M, Anyaoku V, Koistinen R, Seppälä M, Franks S.
    Clin Endocrinol (Oxf); 1995 Aug 01; 43(2):159-65. PubMed ID: 7554310
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.